Larvol Delta - Safety-of-Recombinant-Human-IL21expressing-Oncolytic-Vaccinia-Virus-Injection-hV01-in-Advanced-Tumors

hV01 - ConVerd

http://clinicaltrials.gov/ct2/show/NCT05914376

Sep 12, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next